Cathy Wood Arc Robox, Rocco, Opath as markets that take a decline – Ark Fintch Innovation ETF (Arca: Arkf), ABSCI (NASDAQ: Absi)
Friday, Cathy Wood– Ark Invest Some important deals were made, with a noticeable activity on stocks such as Robox Corp RBLXfor Roku Inc. Roccofor UIPATH Inc. roadfor Ibotta inc. Ibtafor Personalis Inc. PSNLfor Absci Corp. AbsiAnd Pharmaceuticals Inc. Rxrx.
RBLX Trading
Ark Invest has sold Roblox Corp shares via multiple ETFS. the Ark Fintech Innovation Etf ARKFfor Ark Innovation Etf ARKKAnd Ark Generation Etf the next generation ARKW Funds were sold 1394, 1919 and 6558 shares, respectively. The move came when Roblox closed at $ 57.17, a decrease of 2.39 % per day.
The total value of the sold shares, calculated from the latest closing price, is about $ 568,000.
Rocco Trade
Roku Inc shares have also been sold via ARKF, Arkk and Arkw funds, which total 3615, 6910 and 17704, respectively. Rocco shares were closed at $ 76.67, a decrease of 3.68 % a day.
The total value of the sold shares, calculated from the latest closing price, is about $ 2.3 million.
Trade Trading
shares UIPATH Inc It was sold via ARKK, Ark Technology & Robotics Etf ARKQAnd ARKW money, total 237840, 11003, and 83559 shares, respectively. UIPATH shares are closed at $ 12.31, an increase of 4.77 % a day.
The total value of the sold shares, calculated from the latest closing price, is about $ 3.6 million.
IBTA, PSNL, Absi and RXRX deals
On the purchase side, the Ark Invest added the shares of IBOTTA Inc, Personalis Inc, Absci Corp and Recursion Parmaceuticals Inc to ARKF and Arkg money. The total value of these purchases, calculated from the latest closing prices, is about $ 2.8 million.
Read the following:
Slip: This content was partially produced with the help of artificial intelligence tools and was reviewed and published by Beenzinga editors.
Compliment image: Shutterstock
batch16.78
growth69.81
quality–
value6.00
Market news and data brought to you benzinga Apis
© 2025 benzinga.com. Benzinga does not provide investment advice. All rights reserved.